Search Result

Results for "

30A5

" in MedChemExpress (MCE) Product Catalog:

By Targets:	MicroRNA (20) Potassium Channel (1) Small Interfering RNA (siRNA) (1) VEGFR (3)
By Research Areas:	Cancer (8) Inflammation/Immunology (1) Metabolic Disease (1) Neurological Disease (1)

Inhibitors & Agonists

Natural
Products

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-R00535

*hsa-miR-30a-5p mimic*	MicroRNA	Cancer
hsa-miR-30a-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-30a-5p mimic hsa-miR-30a-5p mimic

HY-RI00535

*hsa-miR-30a-5p inhibitor*	MicroRNA
hsa-miR-30a-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-30a-5p inhibitor hsa-miR-30a-5p inhibitor

HY-RS13183

SLC30A5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
SLC30A5 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC30A5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLC30A5 Human Pre-designed siRNA Set A SLC30A5 Human Pre-designed siRNA Set A

HY-R00535A

*hsa-miR-30a-5p agomir*	MicroRNA
hsa-miR-30a-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30a-5p agomir hsa-miR-30a-5p agomir

HY-RI00535A

*hsa-miR-30a-5p antagomir*	MicroRNA
hsa-miR-30a-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30a-5p antagomir hsa-miR-30a-5p antagomir

HY-N9960

α-Isopropylmalate

α-IPM
Others Others

α-Isopropylmalate (α-IPM) is the leucine biosynthetic precursor in Yeast .

α-Isopropylmalate α-IPM	Others	Others
α-Isopropylmalate (α-IPM) is the leucine biosynthetic precursor in Yeast .

HY-R00537

*hsa-miR-30b-5p mimic*	MicroRNA	Cancer
hsa-miR-30b-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-30b-5p mimic hsa-miR-30b-5p mimic

HY-R00540

*hsa-miR-30c-5p mimic*	MicroRNA	Cancer
hsa-miR-30c-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-30c-5p mimic hsa-miR-30c-5p mimic

HY-R00542

*hsa-miR-30d-5p mimic*	MicroRNA	Cancer
hsa-miR-30d-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-30d-5p mimic hsa-miR-30d-5p mimic

HY-R00544

*hsa-miR-30e-5p mimic*	MicroRNA	Cancer
hsa-miR-30e-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-30e-5p mimic hsa-miR-30e-5p mimic

HY-N10436

Anti-inflammatory agent 30

Others Metabolic Disease Inflammation/Immunology

Anti-inflammatory agent 30 (Compound 5) is an anti-inflammatory agent with hepatoprotective activity .

Anti-inflammatory agent 30	Others	Metabolic Disease Inflammation/Immunology
Anti-inflammatory agent 30 (Compound 5) is an anti-inflammatory agent with hepatoprotective activity .

HY-RI00537

*hsa-miR-30b-5p inhibitor*	MicroRNA
hsa-miR-30b-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-30b-5p inhibitor hsa-miR-30b-5p inhibitor

HY-RI00540

*hsa-miR-30c-5p inhibitor*	MicroRNA
hsa-miR-30c-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-30c-5p inhibitor hsa-miR-30c-5p inhibitor

HY-RI00542

*hsa-miR-30d-5p inhibitor*	MicroRNA
hsa-miR-30d-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-30d-5p inhibitor hsa-miR-30d-5p inhibitor

HY-RI00544

*hsa-miR-30e-5p inhibitor*	MicroRNA
hsa-miR-30e-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-30e-5p inhibitor hsa-miR-30e-5p inhibitor

HY-R00537A

*hsa-miR-30b-5p agomir*	MicroRNA
hsa-miR-30b-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30b-5p agomir hsa-miR-30b-5p agomir

HY-R00540A

*hsa-miR-30c-5p agomir*	MicroRNA
hsa-miR-30c-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30c-5p agomir hsa-miR-30c-5p agomir

HY-R00542A

*hsa-miR-30d-5p agomir*	MicroRNA
hsa-miR-30d-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30d-5p agomir hsa-miR-30d-5p agomir

HY-R00544A

*hsa-miR-30e-5p agomir*	MicroRNA
hsa-miR-30e-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30e-5p agomir hsa-miR-30e-5p agomir

HY-136615

5-Hydroxydecanoate sodium	Potassium Channel	Neurological Disease
5-Hydroxydecanoate sodium is a selective ATP-sensitive K ⁺ (K_ATP) channel blocker (IC₅₀ of ~30 μM). 5-Hydroxydecanoate sodium is a substrate for mitochondrial outer membrane acyl-CoA synthetase and has antioxidant activity .

HY-RI00537A

*hsa-miR-30b-5p antagomir*	MicroRNA
hsa-miR-30b-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30b-5p antagomir hsa-miR-30b-5p antagomir

HY-RI00540A

*hsa-miR-30c-5p antagomir*	MicroRNA
hsa-miR-30c-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30c-5p antagomir hsa-miR-30c-5p antagomir

HY-RI00542A

*hsa-miR-30d-5p antagomir*	MicroRNA
hsa-miR-30d-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30d-5p antagomir hsa-miR-30d-5p antagomir

HY-RI00544A

*hsa-miR-30e-5p antagomir*	MicroRNA
hsa-miR-30e-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-30e-5p antagomir hsa-miR-30e-5p antagomir

HY-10977

Tivozanib Maximum Cited Publications 6 Publications Verification AV-951; KRN951	VEGFR	Cancer
Tivozanib (AV-951; KRN951) is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC₅₀s of 30, 6.5 and 15 nM, respectively. Tivozanib exhibits antitumor efficacy .

HY-10977A

Tivozanib hydrochloride hydrate Maximum Cited Publications 6 Publications Verification AV-951 hydrochloride hydrate; KRN951 hydrochloride hydrate	VEGFR	Cancer
Tivozanib hydrochloride hydrate is the hydrate hydrochloride form of Tivozanib (HY-10977). Tivozanib hydrochloride hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC₅₀s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrochloride hydrate exhibits antitumor efficacy .

HY-112467

Tivozanib hydrate AV-951 hydrate; KRN951 hydrate	VEGFR	Cancer
Tivozanib hydrate (AV-951 hydrate; KRN951 hydrate) is the hydrate form of Tivozanib (HY-10977). Tivozanib hydrate is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC₅₀s of 30, 6.5 and 15 nM, respectively. Tivozanib hydrate exhibits antitumor efficacy .

α-Isopropylmalate α-IPM	Structural Classification Microorganisms Animals Ketones, Aldehydes, Acids Source classification	Others
α-Isopropylmalate (α-IPM) is the leucine biosynthetic precursor in Yeast .

Anti-inflammatory agent 30	Source classification Phenols Dicerothamnus rhinocerotis Plants Umbelliferae	Others
Anti-inflammatory agent 30 (Compound 5) is an anti-inflammatory agent with hepatoprotective activity .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.

30A5

Inhibitors & Agonists

NaturalProducts

Natural
Products